768 reports of this reaction
3.1% of all DIPHENHYDRAMINE HCL reports
#1 most reported adverse reaction
COMPLETED SUICIDE is the #1 most commonly reported adverse reaction for DIPHENHYDRAMINE HCL, manufactured by Meijer Distribution Inc. There are 768 FDA adverse event reports linking DIPHENHYDRAMINE HCL to COMPLETED SUICIDE. This represents approximately 3.1% of all 24,504 adverse event reports for this drug.
Patients taking DIPHENHYDRAMINE HCL who experience completed suicide should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
COMPLETED SUICIDE is moderately reported among DIPHENHYDRAMINE HCL users, representing a notable but not dominant share of adverse events.
In addition to completed suicide, the following adverse reactions have been reported for DIPHENHYDRAMINE HCL:
The following drugs have also been linked to completed suicide in FDA adverse event reports:
COMPLETED SUICIDE has been reported as an adverse event in 768 FDA reports for DIPHENHYDRAMINE HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
COMPLETED SUICIDE accounts for approximately 3.1% of all adverse event reports for DIPHENHYDRAMINE HCL, making it one of the most commonly reported side effect.
If you experience completed suicide while taking DIPHENHYDRAMINE HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.